Molecular Epidemiology and Resistance of C. auris in Guangzhou: Insights for Laboratory Surveillance

Study Background and Research Question

Candidozyma auris (formerly Candida auris) has rapidly emerged as a global health concern due to its multidrug resistance, high transmission potential, and ability to cause nosocomial outbreaks. First identified in Japan in 2009, C. auris cases have since spread across six continents, prompting the World Health Organization to classify it as a high-priority fungal pathogen. In China, the incidence of C. auris is rising, yet regional molecular epidemiological data, especially from South China, have remained scarce. The reference study by Wan et al. sought to address this knowledge gap by characterizing the genetic diversity, antifungal resistance, and virulence of C. auris isolates from hospitals in Guangzhou, providing a foundation for improved infection control and surveillance strategies [Wan et al., 2026].

Key Innovation from the Reference Study

This investigation is the first to perform comprehensive whole genome sequencing (WGS) and phenotypic profiling of C. auris isolates in Guangzhou. By integrating SNP-based phylogenetic analysis, antifungal susceptibility testing, and virulence assays, the study delineates the local clade structure and links genetic signatures to clinically relevant resistance and pathogenicity features. Notably, the study identifies the coexistence of two major global clades (Clade I and Clade III) in the Guangzhou hospital setting, a finding that informs both regional and international surveillance efforts [Wan et al., 2026].

Methods and Experimental Design Insights

The research team obtained 39 non-duplicate C. auris isolates from 37 patients treated at three hospitals in Guangzhou. The methodological framework included:

• Whole Genome Sequencing (WGS): High-resolution SNP analyses were conducted to determine clade membership and phylogenetic relationships among local isolates.
• Antifungal Susceptibility Testing: Standardized microdilution assays measured responses to major antifungal classes (azoles, echinocandins, polyenes).
• Resistance Gene Profiling: WGS data were analyzed for ERG11, FKS1, and other known resistance-associated mutations.
• Virulence Phenotypes: Secreted aspartyl protease (SAP) activity was quantified, and biofilm formation was assessed under controlled conditions. Pathogenicity was evaluated using a Galleria mellonella infection model to simulate host responses.

This integrative approach enabled the authors to correlate genotype with phenotype, providing a robust platform for epidemiological and functional studies [Wan et al., 2026].

Protocol Parameters

• biofilm formation assay | quantification via crystal violet staining (absorbance at 570 nm) | applicable to in vitro virulence assessment | enables robust comparison of biofilm capacity across clades | paper [Wan et al., 2026]
• cell viability/proliferation (Galleria mellonella model) | survival rate over 72 h post-infection | models in vivo pathogenicity | reflects clinical virulence potential | paper [Wan et al., 2026]
• crystal violet staining solution concentration | 2% (w/v) alkaline solution | standard for nuclear staining dye protocols | ensures reproducible nuclear staining in biofilm and colony assays | workflow_recommendation
• antifungal susceptibility testing | CLSI/EUCAST breakpoints | determines clinical resistance | guides antifungal therapy and stewardship | paper [Wan et al., 2026]

Core Findings and Why They Matter

The study’s main findings are as follows:

• Clade Distribution: Two major clades were identified: Clade I (74.4% of isolates) and Clade III (25.6%), with one patient harboring both clades simultaneously. This highlights the complexity of C. auris transmission dynamics in the region [Wan et al., 2026] [source_type: paper].
• Antifungal Resistance: All isolates exhibited resistance to fluconazole, underpinned by ERG11 mutations (K143R or F126L). Clade I isolates showed high-level resistance to amphotericin B, while echinocandin sensitivity was preserved in all strains. Notably, no FKS1 mutations (associated with echinocandin resistance) were detected [Wan et al., 2026] [source_type: paper].
• Virulence Mechanisms: Clade I isolates demonstrated elevated secreted aspartyl protease activity, correlating with increased mortality in the Galleria mellonella infection model. Conversely, Clade III isolates were superior in biofilm formation, a phenotype linked to environmental persistence and colonization potential [Wan et al., 2026] [source_type: paper].

These findings inform both diagnostic and infection control strategies. For example, strong biofilm formation in Clade III may necessitate enhanced environmental cleaning protocols in hospital settings. The identification of ERG11 mutations as a universal feature of fluconazole resistance in this cohort supports the use of molecular diagnostics for rapid resistance prediction.

Comparison with Existing Internal Articles

The current study’s use of crystal violet staining to quantify biofilm formation aligns directly with established workflows described in internal resources such as "Crystal Violet Staining Solution: Robust Protocols for Cell-Based Assays". That article provides practical troubleshooting and optimization for colony formation and biofilm assays using 2% crystal violet dye, reinforcing the reproducibility and sensitivity highlighted in the reference paper [source_type: product_spec|workflow_recommendation].

Additional internal guides, such as "Crystal Violet Staining Solution: Precision Nuclear Stain", emphasize the importance of consistent nuclear staining dye performance for cell proliferation and migration studies, which are methodologically analogous to the virulence and viability assays presented by Wan et al. These resources collectively support the use of standardized crystal violet staining protocols to ensure reliable quantification in both basic and translational research contexts.

Limitations and Transferability

While the study significantly advances our understanding of C. auris epidemiology in Guangzhou, several limitations should be noted. The sample size, though substantial for a single region, may not capture the full genetic diversity of C. auris circulating in China. The use of the Galleria mellonella infection model, while widely accepted for preliminary virulence screening, does not fully recapitulate mammalian host responses. Furthermore, environmental sampling was not performed, leaving gaps in our knowledge of hospital transmission routes. Nevertheless, the core methodologies—especially WGS-based clade assignment and standardized biofilm/virulence assays—are directly transferable to other institutional settings and can be adapted for broader surveillance efforts [source_type: paper|workflow_recommendation].

Research Support Resources

Researchers aiming to replicate or extend the biofilm, colony formation, or cell viability assays described by Wan et al. can leverage established reagents such as the Crystal Violet Staining Solution (SKU K1184) from APExBIO. This 2% alkaline nuclear staining dye is optimized for robust and reproducible visualization of cellular architecture in a wide array of cell proliferation, migration, and biofilm assays, as outlined in both the reference study and internal protocol guides [internal resource] [source_type: product_spec]. For long-term reliability, the solution should be stored at room temperature, protected from light, with stability maintained for up to one year [source_type: product_spec].